PMC:7172841 / 11977-12275
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T54","span":{"begin":51,"end":60},"obj":"Body_part"},{"id":"T55","span":{"begin":87,"end":96},"obj":"Body_part"}],"attributes":[{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A55","pred":"fma_id","subj":"T55","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T120","span":{"begin":144,"end":152},"obj":"Disease"},{"id":"T121","span":{"begin":144,"end":148},"obj":"Disease"},{"id":"T122","span":{"begin":280,"end":288},"obj":"Disease"},{"id":"T123","span":{"begin":294,"end":297},"obj":"Disease"}],"attributes":[{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A122","pred":"mondo_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T71","span":{"begin":1,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T72","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T73","span":{"begin":87,"end":96},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T74","span":{"begin":198,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T57","span":{"begin":28,"end":37},"obj":"Chemical"},{"id":"T58","span":{"begin":61,"end":68},"obj":"Chemical"},{"id":"T59","span":{"begin":75,"end":77},"obj":"Chemical"}],"attributes":[{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A59","pred":"chebi_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T98","span":{"begin":0,"end":97},"obj":"Sentence"},{"id":"T99","span":{"begin":98,"end":298},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T221","span":{"begin":28,"end":37},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T222","span":{"begin":45,"end":50},"obj":"SP_6;NCBITaxon:9606"},{"id":"T223","span":{"begin":51,"end":60},"obj":"CL:0000738"},{"id":"T224","span":{"begin":61,"end":68},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T225","span":{"begin":82,"end":86},"obj":"PR:000001889"},{"id":"T226","span":{"begin":87,"end":96},"obj":"CL:0000576"},{"id":"T227","span":{"begin":112,"end":121},"obj":"NCBITaxon:2"},{"id":"T228","span":{"begin":144,"end":154},"obj":"SP_7"},{"id":"T229","span":{"begin":191,"end":197},"obj":"UBERON:0002405;GO:0006955"},{"id":"T230","span":{"begin":198,"end":208},"obj":"GO:0042110"},{"id":"T231","span":{"begin":244,"end":253},"obj":"NCBITaxon:2"},{"id":"T232","span":{"begin":262,"end":275},"obj":"GO:0065007"},{"id":"T233","span":{"begin":280,"end":288},"obj":"SP_7"},{"id":"T92925","span":{"begin":28,"end":42},"obj":"GO:0019814"},{"id":"T35504","span":{"begin":66,"end":81},"obj":"SP_7"},{"id":"T59865","span":{"begin":93,"end":96},"obj":"GO:0071735"},{"id":"T4129","span":{"begin":115,"end":118},"obj":"GO:0071735"},{"id":"T21016","span":{"begin":167,"end":177},"obj":"SP_7"},{"id":"T96566","span":{"begin":236,"end":241},"obj":"UBERON:0002405;GO:0006955"},{"id":"T19391","span":{"begin":242,"end":252},"obj":"GO:0006955"},{"id":"T65950","span":{"begin":268,"end":281},"obj":"GO:0065007"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"376","span":{"begin":82,"end":86},"obj":"Gene"},{"id":"377","span":{"begin":98,"end":106},"obj":"Species"},{"id":"378","span":{"begin":144,"end":154},"obj":"Species"},{"id":"379","span":{"begin":45,"end":50},"obj":"Species"},{"id":"380","span":{"begin":224,"end":239},"obj":"Disease"},{"id":"381","span":{"begin":280,"end":288},"obj":"Disease"}],"attributes":[{"id":"A376","pred":"tao:has_database_id","subj":"376","obj":"Gene:929"},{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"Tax:9606"},{"id":"A378","pred":"tao:has_database_id","subj":"378","obj":"Tax:2697049"},{"id":"A379","pred":"tao:has_database_id","subj":"379","obj":"Tax:9606"},{"id":"A381","pred":"tao:has_database_id","subj":"381","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(A) Absolute numbers of the molecules of the human leukocyte antigen (mHLA-DR) on CD14 monocytes. Patients with bacterial CAP and CAP caused by SARS-CoV-2 are classified into three states of immune activation: intermediate, immunoparalysis for bacterial CAP and dysregulation for COVID-19, and MAS."}